Ciliary neurotrophic factor receptor

From WikiMD's Medical Encyclopedia

Revision as of 10:50, 10 February 2025 by Prab (talk | contribs) (CSV import)

Ciliary Neurotrophic Factor Receptor (CNTFR) is a protein that in humans is encoded by the CNTFR gene. It is a component of a multi-subunit receptor complex, the ciliary neurotrophic factor (CNTF) receptor, which also includes two other proteins: LIF receptor (LIFR) and gp130.

Function

The CNTFR is part of the receptor system for ciliary neurotrophic factor, a protein that promotes the survival of various neuronal cell types and may play an important role in the injury-induced response of neurons. The CNTFR does not have a transmembrane domain, unlike many other growth factor receptors, and therefore cannot function by itself. Instead, it requires the other two components of the CNTF receptor - LIFR and gp130 - to mediate cellular response to CNTF.

Structure

The CNTFR is a glycosylated protein with a molecular weight of approximately 60 kDa. It consists of an extracellular domain, a single transmembrane domain, and a short cytoplasmic tail. The extracellular domain of the CNTFR is responsible for binding to CNTF, while the transmembrane domain and cytoplasmic tail are required for association with LIFR and gp130.

Clinical Significance

Mutations in the CNTFR gene have been associated with motor neuron disease and Hirschsprung's disease. In addition, the CNTFR has been implicated in the pathogenesis of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.

See Also

References

Stub icon
   This article is a protein-related stub. You can help WikiMD by expanding it!




Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.